<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 22 Jul 2026 12:05:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</link>
   <description>
&lt;p&gt;SAN DIEGO, California and SEOUL, Republic of Korea, July  22, 2026  (GLOBE NEWSWIRE) -- Vivasor, Inc. (&amp;quot;Vivasor&amp;quot;), a clinical-stage biopharmaceutical holding company advancing a diversified portfolio of innovative therapies, today announced the execution of an Exclusive Strategic Representation Agreement with JP3E Development Corp. (OTC: JPTE) (&amp;quot;JP3E&amp;quot;), establishing JP3E as Vivasor&amp;apos;s exclusive strategic representative and business development agent in the Republic of Korea.&lt;/p&gt;  &lt;p&gt;The strategic collaboration positions Vivasor to capitalize on South Korea&amp;apos;s rapidly expanding pharmaceutical and biotechnology ecosystem by identifying, coordinating, and facilitating high-value opportunities across licensing, commercialization, manufacturing, investment, and strategic partnerships.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Strategic Partnership Overview&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vivasor+Appoints+JP3E+Development+Corp.+%28JP+3E+Holdings%2C+Inc.+%28JPTE%29+Majority+Owned+Subsidiary%29+as+Exclusive+Strategic+Representative+in+the+Republic+of+Korea/26800466.html</guid>
   <pubDate>Wed, 22 Jul 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37477897</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213523</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50217020</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00185936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35116206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65888988</category>
   	  </item>
  <item>
   <title>JP 3E Holdings and iYap Global sign Korea digital commerce deal</title>
   <link>http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC: JPTE) and iYap Global announced the execution of a Master License and Strategic Partnership Framework Agreement on July 8, 2026, aimed at deploying iYap's AI-powered digital commerce platform across South Korea.&lt;/p&gt;

&lt;p&gt;Under the agreement, JP 3E will lead deployment, merchant onboarding, regulatory coordination, and commercial expansion of the iYap ecosystem in Korea. iYap Global will provide the underlying AI-powered platform, digital payment technologies, and ongoing technical support.&lt;/p&gt;

&lt;p&gt;The partnership targets the phased deployment of up to 50,000 AI-powered digital payment nodes nationwide. The companies said they plan to establish a Joint Governance Committee to oversee implementation and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</guid>
   <pubDate>Wed, 08 Jul 2026 08:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57255660</category>
   	  </item>
  <item>
   <title>JP 3E Holdings and iYap Global sign Korea digital commerce deal</title>
   <link>http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC: JPTE) and iYap Global announced the execution of a Master License and Strategic Partnership Framework Agreement on July 8, 2026, aimed at deploying iYap's AI-powered digital commerce platform across South Korea.&lt;/p&gt;

&lt;p&gt;Under the agreement, JP 3E will lead deployment, merchant onboarding, regulatory coordination, and commercial expansion of the iYap ecosystem in Korea. iYap Global will provide the underlying AI-powered platform, digital payment technologies, and ongoing technical support.&lt;/p&gt;

&lt;p&gt;The partnership targets the phased deployment of up to 50,000 AI-powered digital payment nodes nationwide. The companies said they plan to establish a Joint Governance Committee to oversee implementation and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</guid>
   <pubDate>Wed, 08 Jul 2026 08:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57255660</category>
   	  </item>
  <item>
   <title>JP 3E Holdings and iYap Global sign Korea digital commerce deal</title>
   <link>http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC: JPTE) and iYap Global announced the execution of a Master License and Strategic Partnership Framework Agreement on July 8, 2026, aimed at deploying iYap's AI-powered digital commerce platform across South Korea.&lt;/p&gt;

&lt;p&gt;Under the agreement, JP 3E will lead deployment, merchant onboarding, regulatory coordination, and commercial expansion of the iYap ecosystem in Korea. iYap Global will provide the underlying AI-powered platform, digital payment technologies, and ongoing technical support.&lt;/p&gt;

&lt;p&gt;The partnership targets the phased deployment of up to 50,000 AI-powered digital payment nodes nationwide. The companies said they plan to establish a Joint Governance Committee to oversee implementation and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</guid>
   <pubDate>Wed, 08 Jul 2026 08:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57255660</category>
   	  </item>
  <item>
   <title>JP 3E Holdings and iYap Global sign Korea digital commerce deal</title>
   <link>http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC: JPTE) and iYap Global announced the execution of a Master License and Strategic Partnership Framework Agreement on July 8, 2026, aimed at deploying iYap's AI-powered digital commerce platform across South Korea.&lt;/p&gt;

&lt;p&gt;Under the agreement, JP 3E will lead deployment, merchant onboarding, regulatory coordination, and commercial expansion of the iYap ecosystem in Korea. iYap Global will provide the underlying AI-powered platform, digital payment technologies, and ongoing technical support.&lt;/p&gt;

&lt;p&gt;The partnership targets the phased deployment of up to 50,000 AI-powered digital payment nodes nationwide. The companies said they plan to establish a Joint Governance Committee to oversee implementation and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</guid>
   <pubDate>Wed, 08 Jul 2026 08:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57255660</category>
   	  </item>
  <item>
   <title>JP 3E Holdings and iYap Global sign Korea digital commerce deal</title>
   <link>http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC: JPTE) and iYap Global announced the execution of a Master License and Strategic Partnership Framework Agreement on July 8, 2026, aimed at deploying iYap's AI-powered digital commerce platform across South Korea.&lt;/p&gt;

&lt;p&gt;Under the agreement, JP 3E will lead deployment, merchant onboarding, regulatory coordination, and commercial expansion of the iYap ecosystem in Korea. iYap Global will provide the underlying AI-powered platform, digital payment technologies, and ongoing technical support.&lt;/p&gt;

&lt;p&gt;The partnership targets the phased deployment of up to 50,000 AI-powered digital payment nodes nationwide. The companies said they plan to establish a Joint Governance Committee to oversee implementation and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/JP+3E+Holdings+and+iYap+Global+sign+Korea+digital+commerce+deal/26744825.html</guid>
   <pubDate>Wed, 08 Jul 2026 08:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57255660</category>
   	  </item>
 </channel>
</rss>
